Back to EXEL
Cambridge Investment Research Advisors, Inc. → EXEL
Cambridge Investment Research Advisors, Inc. EXEL Position History
Exelixis, Inc. • Healthcare
Quarters held
6
Latest value
$10.2M
Q3 2026
Peak value
$10.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $8.1M |
| Q4 2025 | $3.8M |
| Q1 2026 | $6.9M |
| Q2 2026 | $4.5M |
| Q2 2026 | $4.5M |
| Q3 2026 | $10.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $10.2M | 174.3K | — | — |
| Q2 2026 | $4.5M | 82.2K | — | — |
| Q2 2026 | $4.5M | 82.2K | — | — |
| Q1 2026 | $6.9M | 159.7K | — | — |
| Q4 2025 | $3.8M | 85.6K | — | — |
| Q3 2025 | $8.1M | 195.1K | — | — |
Other funds holding EXEL
$730.6M